Skip to content
Dr. Grey AI

Supplement

Umckaloabo

Umckaloabo is a herbal extract made from the roots of Pelargonium sidoides, a South African geranium, traditionally used for chest and airway complaints and thought to influence how the body responds to respiratory infections. People mostly look at it for bronchitis, and the evidence is strong: pooled trials, including one in children and adolescents, found bronchitis symptoms improved. Smaller studies pointed to eased asthma symptoms during colds, but that rests on a single trial of 61 children, so it is limited.

Sources: PMID 18222667; PMID 22360575

Best evidence
Grade A
Conditions studied
9
Outcomes
42
Graded outcomes
3321

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

9 conditions

Acute Bronchitis

Acute Bronchitis: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bronchitis Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect4 studies1,012 people
Appetite

Small Increase

Worsens (the measure goes up)Small effect620 people
Lung FunctionImproves (the measure goes up)10 studies4,241 people

Studies that measured lung function

FeverImproves (the measure goes up)2 studies3,237 people
Common Cold SymptomsImproves (the measure goes down)1 study693 people

Studies that measured common cold symptoms

CoughChanges; see studies1 study719 people
Fatigue SymptomsImproves (the measure goes down)3,641 people
HeadachesImproves (the measure goes down)4,261 people
Nausea SymptomsImproves (the measure goes down)620 people
Subjective Well-BeingImproves (the measure goes up)1,111 people

Common Cold: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bronchitis Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect4 studies644 people
FeverImproves (the measure goes up)2 studies131 people
Common Cold SymptomsImproves (the measure goes down)1 study832 people

Studies that measured common cold symptoms

CoughChanges; see studies1 study746 people

Studies that measured cough

Nasal CongestionImproves (the measure goes up)1 study131 people
Upper Respiratory Tract Infection SymptomsImproves (the measure goes down)1 study28 people
HeadachesImproves (the measure goes down)103 people

Acute Bronchitis

  • Bronchitis Symptoms: improves
  • Appetite: worsens
  • Lung Function: improves
Acute Bronchitis: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bronchitis Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect4 studies1,012 people
Appetite

Small Increase

Worsens (the measure goes up)Small effect620 people
Lung FunctionImproves (the measure goes up)10 studies4,241 people

Studies that measured lung function

FeverImproves (the measure goes up)2 studies3,237 people
Common Cold SymptomsChanges; see studies1 study693 people

Studies that measured common cold symptoms

CoughChanges; see studies1 study719 people
Fatigue SymptomsChanges; see studies3,641 people
HeadachesChanges; see studies4,261 people
Nausea SymptomsChanges; see studies620 people
Subjective Well-BeingImproves (the measure goes up)1,111 people

Acute Respiratory Infection (ARI)

  • Bronchitis Symptoms: improves
  • Common Cold Symptoms: improves
  • Nasal Congestion: improves
Acute Respiratory Infection (ARI): outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bronchitis Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect4 studies341 people
Common Cold SymptomsImproves (the measure goes down)1 study1,771 people

Studies that measured common cold symptoms

Nasal CongestionImproves (the measure goes up)1 study1,771 people
Upper Respiratory Tract Infection SymptomsImproves (the measure goes down)1 study990 people

Studies that measured upper respiratory tract infection symptoms

Upper Respiratory Tract Infection

  • Asthma Symptoms: improves
  • Fever: improves
  • Cough: changes; see studies
Upper Respiratory Tract Infection: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Asthma Symptoms

Small Improvement

Improves (the measure goes down)Small effect1 study61 people
FeverImproves (the measure goes up)2 studies61 people
CoughChanges; see studies1 study746 people

Studies that measured cough

Nasal CongestionImproves (the measure goes up)1 study61 people

Immune Health

  • Exercise-Induced Immune Suppression: improves
  • Immunoglobulin A: improves
Immune Health: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Exercise-Induced Immune Suppression

Small Improvement

Improves (the measure goes up)Small effect25 people
Immunoglobulin AImproves (the measure goes up)1 study25 people

Aerobic Exercise Performance

  • Aerobic Exercise Metrics
  • Immunoglobulin A: improves
  • Exercise-Induced Immune Suppression: improves
Aerobic Exercise Performance: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Aerobic Exercise Metrics

No effect

NoneNo effect25 people
Immunoglobulin AImproves (the measure goes up)1 study25 people
Exercise-Induced Immune SuppressionImproves (the measure goes up)25 people
Chronic Obstructive Pulmonary Disease (COPD): outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Lung FunctionImproves (the measure goes up)10 studies199 people

Studies that measured lung function

Sinusitis

  • Nasal Congestion: improves
Sinusitis: outcomes studied for Umckaloabo
GradeOutcomeEffectSizeStudiesPeopleStudies list
Nasal CongestionImproves (the measure goes up)1 study203 people

Key findings

  • Bronchitis SymptomsImproves (the measure goes down)
  • AppetiteWorsens (the measure goes up)
  • Asthma SymptomsUpper Respiratory Tract InfectionImproves (the measure goes down)

Shop the evidence-backed picks

Third-party tested Umckaloabo products, in the forms the graded studies used where we can match them.

  • Grade A

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

22 studies from PubMed

  1. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trialExplore · PMID 16781588
  2. EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trialPlanta Med · PMID 18449849
  3. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and childrenPhytomedicine · PMID 17184981
  4. Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitisActa Paediatr · PMID 20070280
  5. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoidesCurr Med Res Opin · PMID 20387996
  6. EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitisPhytomedicine · PMID 17184984
  7. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre studyCurr Med Res Opin · PMID 17288687
  8. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trialPhytomedicine · PMID 12807337
  9. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides rootsInt J Clin Pharmacol Ther · PMID 20197012
  10. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysisPhytomedicine · PMID 18222667
  11. Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescentsPediatr Int · PMID 22360575
  12. Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life - a meta-analysis of randomized, placebo-controlled trials.Multidiscip Respir Med · PMID 36051888
  13. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trialRhinology · PMID 19382496
  14. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in childrenPhytomedicine · PMID 23142309
  15. Herbal Medicine for Cough: a Systematic Review and Meta-Analysis.Forsch Komplementmed · PMID 26840418
  16. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPDRespir Med · PMID 23478193
  17. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trialExplore · PMID 18005909
  18. The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancyPhytomedicine · PMID 22809962
  19. Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis.Heliyon · PMID 31844762
  20. Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15Phytomedicine · PMID 20850953
  21. Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis.Acad Pediatr · PMID 28610802
  22. Pelargonium sidoides extract for treating acute respiratory tract infections.Cochrane Database Syst Rev · PMID 24146345